Hot Stock List: Rite Aid Corporation (NYSE:RAD), Ophthotech Corporation (NASDAQ:OPHT), Summit Hotel Properties (NYSE:INN), Clovis Oncology (NASDAQ:CLVS), The J. M. Smucker (NYSE:SJM)

Rite Aid Corporation (NYSE:RAD) belongs to Services sector. Its net profit margin is 7.80% and weekly performance is 3.81%. On last trading day company shares ended up $8.71. Rite Aid Corporation (NYSE:RAD) distance from 50-day simple moving average (SMA50) is 3.56%. On 2 July, Rite Aid Corporation (NYSE: RAD) announced sales results for June. For the four weeks ended June 27, 2015, same store sales increased 2.4 percent over the prior-year period. June front-end same store sales increased 0.3 percent. Pharmacy same store sales, which included an approximate 226 basis points negative impact from new generic introductions, increased 3.4 percent. Prescription count at comparable stores increased 0.2 percent over the prior-year period.

Ophthotech Corporation (NASDAQ:OPHT) shares increased 1.58% in last trading session and ended the day at $53.92. OPHT return on assets is -14.10%. Ophthotech Corporation (NASDAQ:OPHT) quarterly performance is 7.86%. Ophthotech Corp (NASDAQ:OPHT)‘s stock had its “buy” rating restated by investment analysts at Stifel Nicolaus in a note issued to investors on Saturday. They currently have a $74.00 price objective on the biopharmaceutical company’s stock, down from their previous price objective of $76.00. Stifel Nicolaus’ price objective indicates a potential upside of 41.25% from the company’s current price.

On 10 July, Summit Hotel Properties, Inc. (NYSE:INN) shares increased 1.72% and was closed at $14.19. INN EPS growth in last 5 year was 14.90%. Summit Hotel Properties, Inc. (NYSE:INN) year to date (YTD) performance is 16.14%. Summit Hotel Properties, Inc. (NYSE:INN) said it recently completed the acquisition of the Hampton Inn located in Boston (Norwood), and the Hotel Indigo located in Asheville for an aggregate purchase price of $59.0 million.

Clovis Oncology, Inc. (NASDAQ:CLVS) ended the last trading day at $80.02. Company weekly volatility is calculated as 4.88% and price to cash ratio as 6.29. Clovis Oncology, Inc. (NASDAQ:CLVS) showed a weekly performance of -3.52%. Clovis Oncology Inc. (NASDAQ:CLVS) announced that the underwriters of its recently announced public offering of its common stock have exercised in full their option to purchase an additional 528,846 shares.

The J. M. Smucker Company (NYSE:SJM) shares fell -0.66% in last trading session and ended the day at $107.59. SJM Gross Margin is 34.70% and its return on assets is 3.10%. The J. M. Smucker Company (NYSE:SJM) quarterly performance is -7.34%. J. M. Smucker (NYSE: SJM) announced that Blue Holdings I, L.P. intends to offer for sale in an underwritten secondary offering 4,921,934 shares of the Company’s common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission (the “SEC”). The Company previously issued to the Selling Shareholder 17,061,079 shares of common stock on March 23, 2015 in connection with the Company’s acquisition of Big Heart Pet Brands.

Leave a Reply

Your email address will not be published. Required fields are marked *